Published in Medical Letter on the CDC and FDA, October 25th, 1999
"This study demonstrates the utility of a dengue laboratory-based surveillance system for the detection of an increase of leptospirosis, which most likely would have gone unrecognized," wrote Eduard J. Sanders, U.S. Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico, and colleagues ("Increase of Leptospirosis in Dengue-Negative Patients after a Hurricane in Puerto Rico in 1966," American Journal of Tropical Medicine and Hygiene, September 1999;61(3):399-404).
Leptospirosis rarely is reported in Puerto Rico. During...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.